| Patents for C07K 19 - Hybrid peptides (29,428) |
|---|
| 11/06/2013 | CN103384677A Compositions for separation methods |
| 11/06/2013 | CN103382480A Asia 1 type foot and mouth disease virus antigen and preparation and application thereof |
| 11/06/2013 | CN102676562B Preparation method and application of fusion protein with broad spectrum adsorption capacity to antibodies |
| 11/06/2013 | CN102585015B Fusion protein containing glicetin-1 as well as preparation method and application |
| 11/06/2013 | CN102391377B Fusion protein capable of inducing and activating cancer targeting T-cells as well as preparation method and application of the fusion protein |
| 11/06/2013 | CN102206282B Efficient method for producing Trx-hCTRP2 |
| 11/06/2013 | CN102115498B Connexin core sequence-containing amphiphilic polypeptide and application thereof |
| 11/06/2013 | CN101628111B Taci-immunoglobulin fusion proteins |
| 11/06/2013 | CN101189334B 抗cd14抗体融合蛋白质 Anti-cd14 antibody fusion proteins |
| 11/05/2013 | US8575309 Delta-opioid receptor selective analgesics |
| 11/05/2013 | CA2645663C Detection of molecular interactions using a reduced affinity enzyme complementation reporter system |
| 11/05/2013 | CA2398979C Novel bee venom polypeptides and methods of use thereof |
| 10/31/2013 | WO2013162760A1 Novel cyclotides with anticancer activity |
| 10/31/2013 | WO2013162746A1 Staphylococcal coagulase antigens and methods of their use |
| 10/31/2013 | WO2013162050A1 Lactoferrin fusion protein and method for producing same |
| 10/31/2013 | WO2013115926A3 Aspartyl-trna synthetase-fc conjugates |
| 10/31/2013 | US20130289251 Binding agent |
| 10/31/2013 | US20130288333 Protein complex using an immunoglobulin fragment and method for the preparation thereof |
| 10/30/2013 | EP2657337A1 Fusion protein |
| 10/30/2013 | EP2655646A2 Targeted perhydrolases |
| 10/30/2013 | EP2655402A1 Oprf/i agents and their use in hospitalized and other patients |
| 10/30/2013 | CN103374579A Plectasin as well as gene and preparation method thereof |
| 10/30/2013 | CN103374066A Alpha B-O-conotoxin and medicine composition and application thereof |
| 10/30/2013 | CN102180971B Recombinant beta-amyloid peptide B cell epitope polypeptide chimeric antigen and preparation method and application thereof |
| 10/29/2013 | US8569481 Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions |
| 10/29/2013 | US8569456 Receptor activator of NF-kappaB |
| 10/29/2013 | US8568731 Staphylococcus aureus antigenic polypeptides and compositions |
| 10/29/2013 | CA2485939C Inducible eukaryotic expression system |
| 10/29/2013 | CA2442363C Reducing the immunogenicity of fusion proteins |
| 10/29/2013 | CA2435672C Polypeptides capable of binding to cd64 and comprising one or more heterologous t cell epitopes, and their uses |
| 10/29/2013 | CA2434643C Peptides for activation and inhibition of.delta.pkc |
| 10/24/2013 | WO2013158841A1 Peptide mimotopes to oxidation specific epitopes |
| 10/24/2013 | WO2013158766A1 Synthetic brassica-derived chloroplast transit peptides |
| 10/24/2013 | WO2013158061A1 Recombinant mycobacterium encoding a heparin-binding hemagglutinin (hbha) fusion protein and uses thereof |
| 10/24/2013 | WO2013155555A1 Peptides for the binding of nucleotide targets |
| 10/24/2013 | WO2008083493A8 Stabilization of cyclic peptide structures |
| 10/23/2013 | CN103370622A Method of diagnosing cancer and diagnosis kit using measurement of NK cell activity |
| 10/23/2013 | CN103370340A Fusion peptide comprising dhFas-1 domain and MMP substrate and use thereof for preventing and treating rheumatoid arthritis |
| 10/23/2013 | CN103370339A Multimeric il-15 soluble fusion molecules and methods of making and using same |
| 10/23/2013 | CN103360498A 一种抗鸡传染性法氏囊病的重组蛋白亚单位疫苗 An anti-IBD recombinant protein subunit vaccines |
| 10/23/2013 | CN103360497A Novel antitumor fusion protein vaccine, and preparation method and application thereof |
| 10/23/2013 | CN102643346B Antibiotic containing antibody simulant and pharmacy application for same |
| 10/23/2013 | CN102516395B Polypeptide carrier used for improving targeting ability and transfection efficiency of medicine/gene, and purpose thereof |
| 10/23/2013 | CN102272304B Sterol side chain-cleaving enzyme protein and use thereof |
| 10/23/2013 | CN102175847B Use method of kit for detecting tetrodotoxin with gene engineering single-chain antibody |
| 10/23/2013 | CN102164949B Nonnatural protein |
| 10/22/2013 | US8563519 Methods of activating or inhibiting G protein coupled receptors (GPCRs) |
| 10/22/2013 | US8563507 Method of treating a disease or condition characterized by aberrant epithelial cell proliferation |
| 10/22/2013 | CA2707726C Novel expression vectors containing accessory molecule ligand genes and their use for immunomodulation and treatment of malignancies and autoimmune disease |
| 10/22/2013 | CA2554089C Albumin fusion proteins |
| 10/22/2013 | CA2526720C Recombinant carrier molecule for expression, delivery and purification of target polypeptides |
| 10/22/2013 | CA2412626C Il-17 molecules and uses thereof |
| 10/17/2013 | WO2012118323A9 Fusion protein comprising albumin and a retinol-binding protein |
| 10/17/2013 | US20130272964 Molecules with extended half-lives, compositions and uses thereof |
| 10/16/2013 | EP2650304A1 Antimicrobial peptide multiblock copolymer to be expressed on surface of cells |
| 10/16/2013 | EP2649088A1 Compositions for separation methods |
| 10/16/2013 | EP2648758A1 Bio-functionalized stimulus-responsive dissolvable peg-hydrogels |
| 10/16/2013 | CN103349781A Modified chimeric polypeptides with improved pharmacokinetic properties |
| 10/16/2013 | CN102286104B Gene for encoding HPV (human papilloma virus) 6-type L2N120E7E6 fusion protein, expression vectors, method, bacteria strain and application |
| 10/16/2013 | CN102276727B IL-17RC-hFc fusion protein and application thereof |
| 10/16/2013 | CN101885778B HPV (Human Papilloma Virus) 16 type L2N120E7E6 fusion protein, gene, preparation method and application |
| 10/15/2013 | US8557967 Anti-interferon-α antibodies |
| 10/15/2013 | US8557771 Homodimer of insulinotropic peptide analogues and method for preparation thereof and use thereof |
| 10/15/2013 | US8557243 EFGR antibodies comprising modular recognition domains |
| 10/15/2013 | US8557242 ERBB2 antibodies comprising modular recognition domains |
| 10/15/2013 | CA2673085C Transferrin fusion protein libraries |
| 10/15/2013 | CA2555013C Carcinoembryonic antigen fusions and uses thereof |
| 10/15/2013 | CA2402214C T1r taste receptors and genes encoding same |
| 10/15/2013 | CA2373721C Compounds that bind her2 |
| 10/10/2013 | WO2013151764A1 Methods and compositions for dengue virus epitopes |
| 10/10/2013 | WO2013151511A1 Modified Dual-Colour Protein |
| 10/10/2013 | WO2013150680A1 Protein tag, tagged protein, and protein purification method |
| 10/10/2013 | WO2013149506A1 Chimeric peptide based on opioid peptide biphalin and neuropeptide ff and synthesis and use thereof |
| 10/10/2013 | WO2013149334A1 Recombinant papaya mosaic virus coat proteins and uses thereof in influenza vaccines |
| 10/10/2013 | WO2013097022A3 Recombinant proteins, polynucleotides and vaccines to combat bovine herpesvirus |
| 10/10/2013 | US20130266573 Specific binding proteins and uses thereof |
| 10/10/2013 | US20130266553 Albumin Fusion Proteins |
| 10/09/2013 | EP2646473A2 Fusion peptide comprising dhfas-1 domain and mmp substrate and use thereof for preventing and treating rheumatoid arthritis |
| 10/09/2013 | EP2646472A1 Covalently dimerized bivalent binding agents |
| 10/09/2013 | EP2646465A1 Generation of multifunctional and multivalent polypeptide complexes with collagen xviii trimerization domain |
| 10/09/2013 | CN103348007A Virus like particle production in plant |
| 10/09/2013 | CN103347514A FGFR1 extracellular domain combination therapies |
| 10/09/2013 | CN103343134A EGF-Fc fusion protein and High-expression production method of mammal expression system of EGF-Fc fusion protein |
| 10/09/2013 | CN103087156B Foot and mouth disease virus (FMDV) antigen polypeptide and vaccine |
| 10/09/2013 | CN102212141B Fusion protein TAT-NANOG, and encoding gene and application thereof |
| 10/09/2013 | CN102134279B Fusion protein and encoding gene thereof as well as application of fusion protein |
| 10/09/2013 | CN101830984B Double-targeted hybrid polypeptide for tumor diagnosis and treatment |
| 10/08/2013 | US8552159 Bifunctional glycoproteins having a modified carbohydrate complement and their use in tumor-selective therapy |
| 10/08/2013 | US8551495 Anti-FMD vaccine composition and preparation and use thereof |
| 10/03/2013 | WO2013149010A1 Enhanced antimicrobial lytic activity of a chimeric ply187 endolysin |
| 10/03/2013 | WO2013148871A1 Engineered polypeptides |
| 10/03/2013 | WO2013148285A1 Methods of inhibiting cell proliferation |
| 10/03/2013 | WO2013148250A1 Tem-1 diagnostic antibodies |
| 10/03/2013 | WO2013148049A1 Recombinant cytotoxic t-lymphocyte-associated protein 4 (ctla4) |
| 10/03/2013 | WO2013147153A1 Anti-lamp5 antibody and utilization thereof |
| 10/03/2013 | WO2013006486A3 Compositions, uses and methods for treatment of metabolic disorders and diseases |
| 10/02/2013 | EP2644616A1 Method for producing web protein, a fused protein, recombinant dna, an expression vector, a host cell and strain-producers |
| 10/02/2013 | CN103339151A Polyvalent chimeric OspC vaccinogen and diagnostic antigen |
| 10/02/2013 | CN103333258A Signal peptide-histone H1 fusion protein, and coding gene and application thereof |
| 10/02/2013 | CN103333257A Fusion protein possessing excellent protecting effects against high-dose radiation and preparation method thereof |